2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia
31
Leukemia, Promyelocytic, Acute
27
Multiple Myeloma
17
Leukemia, Myeloid, Acute
16
Neoplasms, Plasma Cell
12
Myelodysplastic Syndromes
12
Leukemia, Myelomonocytic, Chronic
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Anemia, Refractory, with Excess of Blasts
7
Lymphoma
6
Leukemia, Monocytic, Acute
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Blast Crisis
6
Neoplasms
5
Lymphoma, Non-Hodgkin
5
Lymphoma, Follicular
5
Leukemia, Myelomonocytic, Acute
5
Leukemia, Megakaryoblastic, Acute
5
Leukemia, Erythroblastic, Acute
5
Burkitt Lymphoma
5
Recurrence
4
Myeloproliferative Disorders
4
Myelodysplastic-Myeloproliferative Diseases
4
Lymphoma, Mantle-Cell
4
Lymphoma, Large-Cell, Immunoblastic
4
Lymphoma, Large B-Cell, Diffuse
4
Leukemia, Myeloid, Chronic-Phase
4
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Central Nervous System Neoplasms
4
Interventions
Cyclophosphamide
87
fludarabine
77
fludarabine phosphate
45
Tacrolimus
45
Whole-Body Irradiation
42
Mycophenolic Acid
42
Busulfan
35
Melphalan
32
Antilymphocyte Serum
24
Methotrexate
23
thymoglobulin
22
Standard of Care
22
Rituximab
22
venetoclax
20
Thiotepa
20
Sirolimus
20
Azacitidine
20
Stem Cell Transplantation
18
Granulocyte Colony-Stimulating Factor
18
Practice Guidelines as Topic
17
Cytarabine
16
Bortezomib
16
Nivolumab
15
Filgrastim
15
Specimen Handling
14
Dexamethasone
14
Blood Specimen Collection
14
Cyclosporine
13
Surveys and Questionnaires
12
Mesna
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hematologic Neoplasms
×
Arsenic Trioxide
×
Clear all
NCT07504458
2026-04-16
QUATRO-APL
Quetzal Therapeutics
Phase 3
Recruiting
150 enrolled